Recurrence of HUS due to CD46/MCP mutation after renal transplantation: A role for endothelial microchimerism

American Journal of Transplantation

Volumn 7, Issue 8, 2007, Pages 2047-2051

  Fremeaux Bacchi V ^a   Arzouk, N ^b   Ferlicot, S ^b,c   Charpentier, B ^b,c   Snanoudj, R ^b   Durrbach A ^b,c  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b BICÊTRE HOSPITAL   (France)

^c INSERM   (France)

Author keywords

CD46 MCP; Hemolytic uremic syndrome; Microchimerism; Renal transplantation

Indexed keywords

GLOBULIN; HLA ANTIGEN CLASS 1; MEMBRANE COFACTOR PROTEIN; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; THYMOCYTE ANTIBODY;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; DRUG DOSE REDUCTION; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GRAFT RECIPIENT; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MICROCHIMERISM; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; ANTIGENS, CD46; BIOPSY; CHIMERISM; DNA; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY TRANSPLANTATION; MUTATION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34447127478     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01888.x     Document Type: Article

References (19)

1. Noris M, Brioschi S, Caprioli J et al. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 2003 362 : 1542 1547.
2. Richards A, Kemp EJ, Liszewski MK et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A 2003 100 : 12966 12971.
3. Fremeaux-Bacchi V, Moulton EA, Kavanagh D et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2006 17 : 2017 2025.
4. Neumann HP, Salzmann M, Bohnert-Iwan B et al. Haemolytic uraemic syndrome and mutations of the factor H gene: A registry-based study of German speaking countries. J Med Genet 2003 40 : 676 681.
5. Pirson Y, Lefebvre C, Arnout C, van Ypersele de Strihou C. Hemolytic uremic syndrome in three adult siblings: A familial study and evolution. Clin Nephrol 1987 28 : 250 255.
6. Goodship TH, Liszewski MK, Kemp EJ, Richards A, Atkinson JP. Mutations in CD46, a complement regulatory protein, predispose to atypical HUS. Trends Mol Med 2004 10 : 226 231.
7. Nilsson SC, Karpman D, Vaziri-Sani F et al. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Mol Immunol 2007 44 : 1835 1844.
8. Richards A, Kathryn Liszewski M, Kavanagh D et al. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. Mol Immunol 2007 44 : 111 122.
9. Caprioli J, Noris M, Brioschi S et al. Genetics of HUS: The impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006 108 : 1267 1279.
10. Fremeaux-Bacchi V, Kemp EJ, Goodship JA et al. The development of atypical HUS is influenced by susceptibility factors in factor H and membrane cofactor protein-evidence from two independent cohorts. J Med Genet 2005 42 : 852 856.
11. Dragon-Durey MA, Fremeaux-Bacchi V. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. Springer Semin Immunopathol 2005 27 : 359 374.
12. Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol 2005 16 : 1035 1050.
13. Ichida S, Yuzawa Y, Okada H, Yoshioka K, Matsuo S. Localization of the complement regulatory proteins in the normal human kidney. Kidney Int 1994 46 : 89 96.
14. Schwimmer J, Nadasdy TA, Spitalnik PF, Kaplan KL, Zand MS. De novo thrombotic microangiopathy in renal transplant recipients: A comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. Am J Kidney Dis 2003 41 : 471 419.
15. Barone GW, Gurley BJ, Abul-Ezz SR, Gokden N. Sirolimus-induced thrombotic microangiopathy in a renal transplant recipient. Am J Kidney Dis 2003 42 : 202 206.
16. Saikali JA, Truong LD, Suki WN. Sirolimus may promote thrombotic microangiopathy. Am J Transplant 2003 3 : 229 230.
17. Florman S, Benchimol C, Lieberman K, Burrows L, Bromberg JS. Fulminant recurrence of atypical hemolytic uremic syndrome during a calcineurin inhibitor-free immunosuppression regimen. Pediatr Transplant 2002 6 : 352 325.
18. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, van Es LA, Bruijn JA, van Krieken JH. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001 357 : 33 37.
19. van Poelgeest EP, Baelde HJ, Lagaaij EL et al. Endothelial cell chimerism occurs more often and earlier in female than in male recipients of kidney transplants. Kidney Int 2005 68 : 847 853.